A new variation of therapy, which uses a genetically-engineered virus to help the body create disease-fighting T-cells, shows early promise without evidence of leukaemia, according to research. More than a decade ago, doctors showed dramatic progress in helping infants born with a severe deficiency in their immune systems, a condition known as "bubble boy" disease.
http://ift.tt/1qlxC5W
http://ift.tt/1qlxC5W
No comments:
Post a Comment